[External arterio-venous shunt].
Kim T, Kamikawa S, Sugimoto T.
Nihon Rinsho. 2004 May;62 Suppl 5:133-5.
[External arterio-venous shunt].
Ohtsubo O, Yokota K.
Nihon Rinsho. 1991 Dec;49 Suppl:237-42.
Safety and efficacy of an innovative external support device for de novo arterio-venous fistula creation: a French bicentric experience.
Hauguel A, Firket L, De Blic R, Bonnet M, Michel C, Mallios A.
J Cardiovasc Surg (Torino). 2025 Feb;66(1):30-36. doi: 10.23736/S0021-9509.24.13124-2. Epub 2024 Nov 6.
Role of nitric oxide in the progression of cardiovascular remodeling induced by carotid arterio-venous shunt in rabbits.
Miyamoto T, Takeishi Y, Shishido T, Takahashi H, Itoh M, Kubota I, Tomoike H.
Jpn Heart J. 2003 Jan;44(1):127-37. doi: 10.1536/jhj.44.127.
Blood access.
Butt KM.
Clin Nephrol. 1978 Apr;9(4):138-43.
Treatment of clotting in external arterio-venous shunts with a fibrinolytic enzyme.
Epstein J, Saker B, Marshall V, Kincaid-Smith P.
Med J Aust. 1969 Jul 19;2(3):137-8.
Arteriographic evaluation of the causes of failure of external arterio-venous haemodialysis shunts.
Glasson R, Palmer FJ.
Australas Radiol. 1973 Dec;17(4):429-35. doi: 10.1111/j.1440-1673.1973.tb01480.x.
Temporary arterio-venous shunts to dilate saphenous crossover graft and maintain graft patency.
Aschberg S, Ankarcrona H, Bergstrand O, Björkholm M.
Acta Chir Scand. 1976;142(8):585-7.
Extra-anatomical veno-venous surgical bypass for central vein occlusion in patients with ipsilateral arterio-venous fistula (AVF) for haemodialysis - A single centre experience.
Saravana KS, Zainal AA.
Med J Malaysia. 2017 Feb;72(1):3-6.
Fibromyalgia syndrome pathology and environmental influences on afflictions with medically unexplained symptoms.
Albrecht PJ, Rice FL.
Rev Environ Health. 2016 Jun 1;31(2):281-94. doi: 10.1515/reveh-2015-0040.
